These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12058885)

  • 41. The threat of an avian influenza pandemic.
    Monto AS
    N Engl J Med; 2005 Jan; 352(4):323-5. PubMed ID: 15668220
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza--placebo-controlled double-blind multicenter phase III trial].
    Kashiwagi S; Kudoh S; Watanabe A; Yoshimura I
    Kansenshogaku Zasshi; 2000 Dec; 74(12):1044-61. PubMed ID: 11193557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of oseltamivir during an outbreak of influenza A in a long-term care facility in Taiwan.
    Chang YM; Li WC; Huang CT; Huang CG; Tsao KC; Cheng YH; Chiang SL; Yang SY; Chen CH; Huang YC
    J Hosp Infect; 2008 Jan; 68(1):83-7. PubMed ID: 17945389
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of post-exposure prophylaxis with oseltamivir for those in contacts with influenza patients in pediatric wards].
    Shinjoh M; Sato S; Sugaya N; Mitamura K; Takeuchi Y; Kosaki K; Takahashi T
    Kansenshogaku Zasshi; 2004 Mar; 78(3):262-9. PubMed ID: 15103909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.
    Kawai N; Ikematsu H; Iwaki N; Satoh I; Kawashima T; Maeda T; Miyachi K; Hirotsu N; Shigematsu T; Kashiwagi S
    Clin Infect Dis; 2005 May; 40(9):1309-16. PubMed ID: 15825034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influenza virus neuraminidase inhibitors.
    Gubareva LV; Kaiser L; Hayden FG
    Lancet; 2000 Mar; 355(9206):827-35. PubMed ID: 10711940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
    Hurt AC; Barr IG; Durrant CJ; Shaw RP; Sjogren HM; Hampson AW
    Commun Dis Intell Q Rep; 2003; 27(4):542-7. PubMed ID: 15508516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.
    Hayden FG; Atmar RL; Schilling M; Johnson C; Poretz D; Paar D; Huson L; Ward P; Mills RG
    N Engl J Med; 1999 Oct; 341(18):1336-43. PubMed ID: 10536125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oseltamivir resistance during treatment of influenza A (H5N1) infection.
    de Jong MD; Tran TT; Truong HK; Vo MH; Smith GJ; Nguyen VC; Bach VC; Phan TQ; Do QH; Guan Y; Peiris JS; Tran TH; Farrar J
    N Engl J Med; 2005 Dec; 353(25):2667-72. PubMed ID: 16371632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
    Ward P; Small I; Smith J; Suter P; Dutkowski R
    J Antimicrob Chemother; 2005 Feb; 55 Suppl 1():i5-i21. PubMed ID: 15709056
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections.
    Lee N; Hui DS; Zuo Z; Ngai KL; Lui GC; Wo SK; Tam WW; Chan MC; Wong BC; Wong RY; Choi KW; Sin WW; Lee EL; Tomlinson B; Hayden FG; Chan PK
    Clin Infect Dis; 2013 Dec; 57(11):1511-9. PubMed ID: 24046309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza.
    Nabeshima S; Kashiwagi K; Ajisaka K; Masui S; Takeoka H; Ikematsu H; Kashiwagi S
    J Infect Chemother; 2012 Aug; 18(4):534-43. PubMed ID: 22350323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].
    de Jong JC; Beyer WE; Rimmelzwaan GF; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):73-9. PubMed ID: 14753128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oseltamivir resistance in influenza A (H5N1) infection.
    Gupta RK; Nguyen-Van-Tam JS
    N Engl J Med; 2006 Mar; 354(13):1423-4; author reply 1423-4. PubMed ID: 16571890
    [No Abstract]   [Full Text] [Related]  

  • 55. Neuraminidase inhibitors: progress in the management of influenza.
    Woodhead M; Lavanchy D; Johnston S; Colman P; Fleming D
    Int J Clin Pract; 2000 Nov; 54(9):604-10. PubMed ID: 11220989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Neuraminidase inhibitors in prophylaxis and treatment of influenza].
    Nitsch-Osuch A; Brydak LB; Wardyn AK
    Pol Merkur Lekarski; 2008 Jul; 25(145):67-73. PubMed ID: 18839619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Economic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities.
    Risebrough NA; Bowles SK; Simor AE; McGeer A; Oh PI
    J Am Geriatr Soc; 2005 Mar; 53(3):444-51. PubMed ID: 15743287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of oseltamivir in Dutch nursing homes during the 2004-2005 influenza season.
    van der Sande MA; Ruijs WL; Meijer A; Cools HJ; van der Plas SM
    Vaccine; 2006 Nov; 24(44-46):6664-9. PubMed ID: 16797806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Observations on managing an outbreak of influenza A infection in an aged care facility.
    McCall BJ; Mohr CM; Jarvinen KA
    Commun Dis Intell Q Rep; 2007 Dec; 31(4):410-2. PubMed ID: 18268884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The study on efficacy of oseltamivir for influenza A in children].
    Imamura T; Hosoya M; Oonishi N; Sato K; Katayose M; Kawasaki Y; Suzuki H
    Kansenshogaku Zasshi; 2003 Nov; 77(11):971-6. PubMed ID: 14672010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.